Relationship between ICD implantation volume and treatment parameters of patients receiving an ICD with remote monitoring
Standard
Relationship between ICD implantation volume and treatment parameters of patients receiving an ICD with remote monitoring. / Butter, Christian; Klein, Gunnar; Grönefeld, Gerian; Böcker, Dirk; Suling, Anna; Buchholz, Anika; Felk, Angelika; Hauser, Tino; Wegscheider, Karl; Bänsch, Dietmar.
In: TECHNOL HEALTH CARE, Vol. 32, No. 3, 2024, p. 1583-1593.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Relationship between ICD implantation volume and treatment parameters of patients receiving an ICD with remote monitoring
AU - Butter, Christian
AU - Klein, Gunnar
AU - Grönefeld, Gerian
AU - Böcker, Dirk
AU - Suling, Anna
AU - Buchholz, Anika
AU - Felk, Angelika
AU - Hauser, Tino
AU - Wegscheider, Karl
AU - Bänsch, Dietmar
PY - 2024
Y1 - 2024
N2 - BACKGROUND: Both highly specialized heart centres and less specialized hospitals care for patients with implantable ICDs/CRT-Ds with remote monitoring.OBJECTIVE: To investigate potential differences in patient treatment according to centre's ICD implantation volume.METHODS: Based on their 2012 ICD/CRT-D implantation volume, centres enrolled in the NORDIC ICD trial in Germany were assigned to one of three groups: high- (HV, n= 345), medium- (MV, n= 340) or low-volume (LV, n= 189).RESULTS: The HV-centres had a significant higher CRT-D proportion (41.7%; LV: 36.5%; MV: 23.2%; Pd454;d459;d45c;d44f;d44e;d459;< 0.001), significant shorter median procedure duration (49 min; MV: 58 min; LV: 60 min; Pd454;d459;d45c;d44f;d44e;d459;< 0.001) but significant longer median hospital stay (4 days; MV and LV: 3 days; Pd454;d459;d45c;d44f;d44e;d459;< 0.001) compared to MV- and LV-centres. The X-ray exposure was shorter in MV/HV-centres (MV: 3.4 min; HV: 3.6 min; LV: 5.5 min; Pd454;d459;d45c;d44f;d44e;d459;< 0.001). Only 3.5% (LV: 2.6%; HV: 3.5%; MV: 4.1%) patients received at least one delivered inappropriate shock and 2.5% (HV: 2.0%; LV: 2.6%; MV: 2.9%) patients had withheld inappropriate ICD shocks without subsequent inappropriate shock delivery within 24.5 months of median follow-up.CONCLUSION: Implantation volume-dependent differences were observed in the device selection, procedure duration and x-ray exposure duration. Remote monitoring in combination with adequate response pattern prevented imminent inappropriate shocks in all three groups.
AB - BACKGROUND: Both highly specialized heart centres and less specialized hospitals care for patients with implantable ICDs/CRT-Ds with remote monitoring.OBJECTIVE: To investigate potential differences in patient treatment according to centre's ICD implantation volume.METHODS: Based on their 2012 ICD/CRT-D implantation volume, centres enrolled in the NORDIC ICD trial in Germany were assigned to one of three groups: high- (HV, n= 345), medium- (MV, n= 340) or low-volume (LV, n= 189).RESULTS: The HV-centres had a significant higher CRT-D proportion (41.7%; LV: 36.5%; MV: 23.2%; Pd454;d459;d45c;d44f;d44e;d459;< 0.001), significant shorter median procedure duration (49 min; MV: 58 min; LV: 60 min; Pd454;d459;d45c;d44f;d44e;d459;< 0.001) but significant longer median hospital stay (4 days; MV and LV: 3 days; Pd454;d459;d45c;d44f;d44e;d459;< 0.001) compared to MV- and LV-centres. The X-ray exposure was shorter in MV/HV-centres (MV: 3.4 min; HV: 3.6 min; LV: 5.5 min; Pd454;d459;d45c;d44f;d44e;d459;< 0.001). Only 3.5% (LV: 2.6%; HV: 3.5%; MV: 4.1%) patients received at least one delivered inappropriate shock and 2.5% (HV: 2.0%; LV: 2.6%; MV: 2.9%) patients had withheld inappropriate ICD shocks without subsequent inappropriate shock delivery within 24.5 months of median follow-up.CONCLUSION: Implantation volume-dependent differences were observed in the device selection, procedure duration and x-ray exposure duration. Remote monitoring in combination with adequate response pattern prevented imminent inappropriate shocks in all three groups.
U2 - 10.3233/THC-230641
DO - 10.3233/THC-230641
M3 - SCORING: Journal article
C2 - 37955096
VL - 32
SP - 1583
EP - 1593
JO - TECHNOL HEALTH CARE
JF - TECHNOL HEALTH CARE
SN - 0928-7329
IS - 3
ER -